Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Charles Licata"'
Autor:
Tanya R. Myers, Paige L. Marquez, Julianne M. Gee, Anne M. Hause, Lakshmi Panagiotakopoulos, Bicheng Zhang, Isaac McCullum, Charles Licata, Christine K. Olson, Shakeeb Rahman, Sharon B. Kennedy, Matthew Cardozo, Chirayu R. Patel, Liza Maxwell, Joel R. Kallman, David K. Shay, Tom T. Shimabukuro
Publikováno v:
Vaccine. 41:1310-1318
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::88d4071baaf46e4b38b14e78f6ef3153
https://doi.org/10.1016/j.vaccine.2022.12.031
https://doi.org/10.1016/j.vaccine.2022.12.031
Autor:
Satoshi Kamidani, Lakshmi Panagiotakopoulos, Charles Licata, Matthew F. Daley, W. Katherine Yih, Ousseny Zerbo, Hung Fu Tseng, Malini B. DeSilva, Jennifer C. Nelson, Holly C. Groom, Joshua T.B. Williams, Simon J. Hambidge, James G. Donahue, Ermias D. Belay, Eric S. Weintraub
Publikováno v:
Pediatrics. 150(6)
BACKGROUND Temporal associations between Kawasaki disease (KD) and childhood vaccines have been reported. Limited data on KD following 13-valent pneumococcal conjugate (PCV13) and rotavirus vaccines are available. METHODS We conducted a self-controll
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::31c6e07226cfc233c407b3d03a12b2fd
https://pubmed.ncbi.nlm.nih.gov/36349537
https://pubmed.ncbi.nlm.nih.gov/36349537
Autor:
Tom T. Shimabukuro, Anne M. Hause, Paige Marquez, Charles Licata, Deborah Thompson, Winston E. Abara, James Baggs, Hannah G. Rosenblum, Tanya R. Myers, David K. Shay, Julianne Gee, John R. Su
Publikováno v:
Morbidity and Mortality Weekly Report
As of July 30, 2021, among the three COVID-19 vaccines authorized for use in the United States, only the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine is authorized for adolescents aged 12-17 years. The Food and Drug Administration (FDA) issued an E
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6bfb3c1a9293714904686d7a88b7e54e
https://doi.org/10.15585/mmwr.mm7031e1
https://doi.org/10.15585/mmwr.mm7031e1
Autor:
Tanya R. Myers, Thomas A. Clark, Ruiling Liu, David K. Shay, Bicheng Zhang, Charles Licata, Julianne Gee, Paige Marquez, John R. Su, Tom T. Shimabukuro
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 70:680-684
On February 27, 2021, the Food and Drug Administration (FDA) issued an Emergency Use Authorization (EUA) for Janssen (Ad.26.COV2.S) COVID-19 vaccine (Janssen Biotech, Inc., a Janssen Pharmaceutical company, Johnson & Johnson) (1). The Janssen COVID-1
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::28cc611e003a57916077c58d58267396
https://doi.org/10.15585/mmwr.mm7018e2
https://doi.org/10.15585/mmwr.mm7018e2
Autor:
Tanya R. Myers, Lakshmi Panagiotakopoulos, Titilope Oduyebo, Dana Meaney-Delman, Paige Marquez, Meghna Alimchandani, Shin Y. Kim, Karen T. Chang, Caitlin Green, Sascha R. Ellington, Stacey W. Martin, Bicheng C. Zhang, Tom T. Shimabukuro, Adamma Mba-Jonas, Pedro L. Moro, Veronica K. Burkel, Ashley N. Smoots, Ruiling Liu, Julianne Gee, Charles Licata, Christine K. Olson
Publikováno v:
The New England Journal of Medicine
Background Many pregnant persons in the United States are receiving messenger RNA (mRNA) coronavirus disease 2019 (Covid-19) vaccines, but data are limited on their safety in pregnancy. Methods From December 14, 2020, to February 28, 2021, we used da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6b6a060f03f3a091b4aac5a7d7297981
https://doi.org/10.1097/01.aoa.0000796052.11696.42
https://doi.org/10.1097/01.aoa.0000796052.11696.42
Autor:
Tom T. Shimabukuro, Nicole P. Lindsey, Ruiling Liu, Stacey W. Martin, Thomas A. Clark, Mark J. Sotir, Lauri E. Markowitz, Paige Marquez, John R. Su, Tanya R. Myers, Charles Licata, Bicheng Zhang, Amelia Jazwa, Julianne Gee, Geoffrey M. Calvert, Narayan Nair
Publikováno v:
Morbidity and Mortality Weekly Report
Two coronavirus disease 2019 (COVID-19) vaccines are currently authorized for use in the United States. The Food and Drug Administration (FDA) issued Emergency Use Authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine on December 11, 2020, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d4242085941e1449758b77e3822db533
https://doi.org/10.15585/mmwr.mm7008e3
https://doi.org/10.15585/mmwr.mm7008e3
Autor:
Bicheng Zhang, Tom T. Shimabukuro, Charles Licata, David K. Shay, James Baggs, Johanna Chapin-Bardales, Julianne Gee, Tanya R. Myers, Paige Marquez
Publikováno v:
Vaccine
Background Post-authorization monitoring of mRNA-based COVID-19 vaccines is needed to better characterize their reactogenicity. We assessed reactions reported during the 2 weeks after receipt of BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) va
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1e00ae41d0f03b6d92e6af1b779b8ccd
https://pubmed.ncbi.nlm.nih.gov/34763946
https://pubmed.ncbi.nlm.nih.gov/34763946